全文获取类型
收费全文 | 3696623篇 |
免费 | 269695篇 |
国内免费 | 7209篇 |
专业分类
耳鼻咽喉 | 52345篇 |
儿科学 | 122087篇 |
妇产科学 | 104757篇 |
基础医学 | 534691篇 |
口腔科学 | 106127篇 |
临床医学 | 335286篇 |
内科学 | 708203篇 |
皮肤病学 | 80385篇 |
神经病学 | 297729篇 |
特种医学 | 140751篇 |
外国民族医学 | 1295篇 |
外科学 | 550196篇 |
综合类 | 83418篇 |
现状与发展 | 6篇 |
一般理论 | 1442篇 |
预防医学 | 297991篇 |
眼科学 | 87036篇 |
药学 | 270445篇 |
9篇 | |
中国医学 | 7467篇 |
肿瘤学 | 191861篇 |
出版年
2018年 | 39060篇 |
2017年 | 29950篇 |
2016年 | 33321篇 |
2015年 | 37944篇 |
2014年 | 53524篇 |
2013年 | 81285篇 |
2012年 | 110450篇 |
2011年 | 118116篇 |
2010年 | 69791篇 |
2009年 | 66105篇 |
2008年 | 110972篇 |
2007年 | 118373篇 |
2006年 | 118871篇 |
2005年 | 116165篇 |
2004年 | 111520篇 |
2003年 | 106800篇 |
2002年 | 104237篇 |
2001年 | 160693篇 |
2000年 | 164696篇 |
1999年 | 139639篇 |
1998年 | 41602篇 |
1997年 | 37283篇 |
1996年 | 37350篇 |
1995年 | 35190篇 |
1994年 | 32736篇 |
1993年 | 30696篇 |
1992年 | 110445篇 |
1991年 | 107926篇 |
1990年 | 105586篇 |
1989年 | 102029篇 |
1988年 | 94815篇 |
1987年 | 92885篇 |
1986年 | 88469篇 |
1985年 | 84665篇 |
1984年 | 64270篇 |
1983年 | 55350篇 |
1982年 | 33568篇 |
1981年 | 30172篇 |
1979年 | 60628篇 |
1978年 | 43420篇 |
1977年 | 36765篇 |
1976年 | 34696篇 |
1975年 | 37496篇 |
1974年 | 45170篇 |
1973年 | 43781篇 |
1972年 | 41446篇 |
1971年 | 38449篇 |
1970年 | 36345篇 |
1969年 | 34370篇 |
1968年 | 32461篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
21.
Arjenne H.M. Gussenhoven Amika S. Singh S. Theo Goverts Marten van Til Johannes R. Anema Sophia E. Kramer 《International journal of audiology》2015,54(8):507-517
Objective: A multidisciplinary vocational rehabilitation programme, the Vocational Enablement Protocol (VEP) was developed to address the specific needs of employees with hearing difficulties. In the current study we evaluated the process of implementing the VEP in audiologic care among employees with hearing impairment. Design: In conjunction with a randomized controlled trial, we collected and analysed data on seven process parameters: recruitment, reach, fidelity, dose delivered, dose received and implemented, satisfaction, and perceived benefit. Study sample: Sixty-six employees with hearing impairment participated in the VEP. The multidisciplinary team providing the VEP comprised six professionals. Results: The professionals performed the VEP according to the protocol. Of the recommendations delivered by the professionals, 31% were perceived as implemented by the employees. Compliance rate was highest for hearing-aid uptake (51%). Both employees and professionals were highly satisfied with the VEP. Participants rated good perceived benefit from it. Conclusions: Our results indicate that the VEP could be a useful treatment for employees with hearing difficulties from a process evaluation perspective. Implementation research in the audiological setting should be encouraged in order to further provide insight into parameters facilitating or hindering successful implementation of an intervention and to improve its quality and efficacy. 相似文献
22.
K.-C. Sung D.-C. Seo S.-J. Lee M.-Y. Lee S.H. Wild C.D. Byrne 《Nutrition, metabolism, and cardiovascular diseases : NMCD》2019,29(5):489-495
Background and aims
It is not known whether non alcoholic fatty liver disease (NAFLD) is a risk factor for diabetes in non obese, non centrally-obese subjects. Our aim was to investigate relationships between fatty liver, insulin resistance and a biomarker score for liver fibrosis with incident diabetes at follow up, in subjects who were neither obese nor centrally-obese.Methods and results
As many as 70,303 subjects with a body mass index (BMI) < 25 kg/m2 and without diabetes were followed up for a maximum of 7.9 years. At baseline, fatty liver was identified by liver ultrasound, insulin resistance (IR) by homeostatic model assessment of insulin resistance (HOMA-IR) ≥2.0, and central obesity by waist circumference (waist circumference ≥90 cm (men) and ≥85 cm (women). The Fibrosis-4 (FIB-4 score) was used to estimate extent of liver fibrosis. Cox proportional hazards models adjusted for confounders were used to estimate hazard ratios (aHRs) for incident diabetes. As many as 852 incident cases of diabetes occurred during follow up (median [IQR] 3.71 [2.03] years). Mean ± SD BMI was 22.8 ± 1.8 and 21.7 ± 2.0 kg/m2 in subjects with and without diabetes at follow up. In subjects without central obesity and with fatty liver, aHRs (95% CI) for incident diabetes at follow up were 2.17 (1.56, 3.03) for men, and 2.86 (1.50,5.46) for women. Similar aHRs for incident diabetes occurred with fatty liver, IR and the highest quartile of FIB-4 combined, in men; and there was a non significant trend toward increased risk in women.Conclusions
In normal weight, non-centrally obese subjects NAFLD is an independent risk factor for incident diabetes. 相似文献23.
24.
25.
26.
27.
According to the current nutritional recommendations issued by professional diabetes and nutrition associations, diabetic patients should keep to a diet consisting of 45–60% carbohydrates, 10–20% protein, and not more than 35% fat. However, not all of these nutritional recommendations are evidence based. For example, current studies show that the intake of insoluble roughage may be underrepresented. It is also possible that diabetic patients could benefit from keeping to the lower end of the recommended range for carbohydrates (45%) and the upper end of the range advised for protein (20%). 相似文献
28.
Chronic transplant dysfunction is a complex dynamic pathogenic process. Clinically, a decrease in glomerular filtration rate (GFR) becomes apparent leading to chronic renal insufficiency and dialysis or death from cardiovascular events. Chronic transplant dysfunction can develop into a chronic alIograft nephropathy (CAN) as a specific entity with dynamic progression. CAN includes a collection of immunologic and non-immunologic factors, rejection, ischemia time, donor and recipient characteristics and toxicity of calcineurin inhibitors. Despite improvements in immunosuppression, the long-range prognosis of renal allografts has not improved. Whether modern immunosuppressive concepts with reduction or avoidance of calcineurin inhibitors and a therapy based on antimetabolites, such as mycophenolate or mTOR-inhibitors could lead to a prolongation of transplant survival, remains to be seen. 相似文献
29.
30.